Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2010
12/08/2010EP2258373A1 Composition comprising taurolidine and/or taurultam for the treatment of cancer
12/08/2010EP2258372A1 A2A antagonists for use in the treatment of motor disorders
12/08/2010EP2258371A1 Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia
12/08/2010EP2258364A1 Preventive and/or remedy for vascular diseases
12/08/2010EP2258363A1 Compositions for treatment of cancers
12/08/2010EP2258361A1 Use of benzophenone derivative or salt thereof and tnf inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
12/08/2010EP2258352A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
12/08/2010EP2258207A1 Pasteurisation process for microbial cells and microbial oil
12/08/2010EP2258166A1 Method for producing founder animal for reproducing animals having lethal phenotype caused by gene modification
12/08/2010EP2257555A1 Thieno[2,3-d]-pyrimidine-4(3h)-one compounds with antifungal properties and process thereof
12/08/2010EP1857108B1 Preventive or therapeutic agent for herpesvirus-related disease
12/08/2010EP1553924B1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
12/08/2010EP1481095B1 Method and nucleic acids for the analysis of colon cell proliferative disorders
12/08/2010EP1455821B1 Parathyroid hormone antibodies and related methods
12/08/2010EP1395284B1 Non-depleting anti-CD4 antibody TRX1 and its uses
12/08/2010EP1276878B1 Reversible immortalization
12/08/2010EP1093457B1 Cytokine receptor common gamma chain like
12/08/2010EP0826041B1 Transforming growth factor alpha hii
12/08/2010EP0772619B2 Immunomodulatory oligonucleotides
12/08/2010CN1981739B Esmolol preparation
12/08/2010CN1977837B Application of monoesters of probucol for the treatment of cardiovascular and inflammatory disease
12/08/2010CN1969975B Formulation for replenishing qi, regenerating blood, tonigying kidney and nourishing face and method for preparing same
12/08/2010CN1803837B Neurotrophic growth factor
12/08/2010CN1778294B Butin and its derivative and its use in preparation of pigmental metabolic disease medicine
12/08/2010CN1742779B Gynostemma pentaphylla oral liquod
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN1530102B Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases
12/08/2010CN1430513B Topical formulations for the transdermal delivery of niacin and method of treating hyperlipidemia
12/08/2010CN101910189A Monosebacate of pyrazole derivative
12/08/2010CN101910182A Antitumor agent
12/08/2010CN101910169A Bicycloamine derivative
12/08/2010CN101910143A Condensed aminodihydrothiazine derivative
12/08/2010CN101909694A Treatment of premature birth complications
12/08/2010CN101909639A Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
12/08/2010CN101909619A Composition comprising sesamin component and quercetin glycoside
12/08/2010CN101909586A External skin preparation for pimpled skin
12/08/2010CN101906464A Proteins producing an altered immunogenic response and methods of making and using the same
12/08/2010CN101906418A Promoter for introducing gene into lymphocyte or blood cell and application thereof
12/08/2010CN101906395A Transformant for blocking chicken myostatin effect by oral immunity and application thereof
12/08/2010CN101906104A 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
12/08/2010CN101906076A Naphthaline amide derivative serving as protein kinase inhibitor and histone deacetylase inhibitor and preparation method and application thereof
12/08/2010CN101905012A Five-retention dispelling wine
12/08/2010CN101904833A Salvianic acid A medical composition and preparation method thereof
12/08/2010CN101904831A Application of alkannin and compositions thereof
12/08/2010CN101508689B Synthesis of oroxylin
12/08/2010CN101411853B Health care medical pillow for strengthening brain and inducing resuscitation
12/08/2010CN101390852B Melanogenesis inhibitor and skin preparation containing the same
12/08/2010CN101371828B Hypocrellin liposome preparation and preparation method thereof
12/08/2010CN101366914B Medicament for tumour restraint, anti-hunger, detoxication, reinforcing phylactic power and preparation method
12/08/2010CN101357162B Traditional Chinese medicine capable of inducing menstruation and removing bloodstasis
12/08/2010CN101301286B Applicaion of brasilein for preparing medicine for treating diseases caused by excess malondialdehyde generated in brain tissue in oxygen-glucose deprivation state
12/08/2010CN101210050B Antibodies for preventing bloodvessel endothelium growth factor
12/08/2010CN101190255B Kudzu root total flavone extracting after steam-explosion process
12/08/2010CN101185726B Cream shape medicine for treating infantile night sweating symptoms
12/08/2010CN101095707B Use of bupleurum root total polyoses in the preparing of medicine for preventing and treating acute respiratory distress syndrome
12/08/2010CN101087615B N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same
12/08/2010CN101076353B Releasable polymer conjugate based on aliphatic biodegradable joint
12/08/2010CN101018537B Wrinkle reduction agent, lipolysis accelerator, composition for external use on skin, and food or beverage composition
12/07/2010US7847095 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1.,2,4-triazol-3-one
12/07/2010US7846967 isolated from Cnidium officinale and Ligusticum chuanxiong; inhibiting melanocyte-stimulating hormone
12/07/2010US7846957 Aromatase inhibition to enhance assisted reproduction
12/07/2010US7846942 Such as 3-isobutyryl-2-isopropyl pyrazolo[1,5-a]pyridine; for treatment of Parkinson's disease, Huntington's disease, Alzheimer's disease, and schizophrenia
12/07/2010US7846928 Interfere with Tie2 signalling; Tie (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain) receptor tyrosine kinase; antitumor, antimetastasis agents; for example, 1-[4-(6-tert-Butyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-phenyl]-3-(3-ethyl-phenyl)-urea
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010US7846924 Cyanopyrroles
12/07/2010US7846916 Steroid on carrier containing pressure sensitive adhesive
12/07/2010US7846911 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia
12/07/2010US7846468 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
12/07/2010US7846453 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3
12/07/2010US7846441 Treatment with anti-ErbB2 antibodies
12/07/2010US7846435 Humanized antibodies that recognize Verotoxin II and cell line producing same
12/07/2010CA2488334C 24-sulfoximine vitamin d3 compounds
12/07/2010CA2482574C Method for the food-technological preparation of potato juice products
12/07/2010CA2471883C Phenylpyrimidine amines as ige inhibitors
12/07/2010CA2460693C Alkyl urea retinoid agonists i
12/07/2010CA2456029C Stable emulsion composition
12/07/2010CA2440111C Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
12/07/2010CA2436409C Kappa opioid receptor ligands
12/07/2010CA2421114C 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
12/07/2010CA2417570C Tumor-specific t cell activation by peptide antigens
12/07/2010CA2398335C Herpes virus strains
12/07/2010CA2381802C Synergistic combination of roflumilast and salmeterol
12/07/2010CA2368850C Methods for the prevention and/or the treatment of glutamate cytotoxicity
12/07/2010CA2352094C High energy phototherapeutic agents
12/07/2010CA2299632C Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
12/07/2010CA2287505C Inhibitors of cellulolytic, xylanolytic and .beta.-glucanolytic enzymes
12/07/2010CA2285516C Dopamine transporter imaging agents
12/07/2010CA2262406C Gene therapy for congestive heart failure
12/07/2010CA2256543C Methods and compositions useful for inhibition of angiogenesis
12/07/2010CA2153653C Growth differentiation factor-9
12/02/2010WO2010138095A1 Medicinal agent
12/02/2010WO2010137654A1 Pharmaceutical composition containing antagonist of egf family ligand as component
12/02/2010WO2010137620A1 Phenoxyethylamine derivative
12/02/2010WO2010137484A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137336A1 NOVEL α-PHENOXYBENZENEACETIC ACID DERIVATIVE AND PHARMACEUTICAL PREPARATION COMPRISING SAME
12/02/2010WO2010136877A1 Muteins of the pyrroline-5-carboxylate reductase 1
12/02/2010WO2010135976A1 1-(substituted benzyl)-5-trifluoromethyl-2-(1h) pyridone compounds and their salts, their preparation methods and use thereof
1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 1564